TDRD9 anticorps (AA 801-900)

N° du produit ABIN1385847

Détail du produit anti-TDRD9 anticorps

Antigène: TDRD9 (Tudor Domain Containing 9 (TDRD9))

Épitope: AA 801-900

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TDRD9 est non-conjugé

Application: ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Homologie: Human,Mouse,Rat,Dog,Cow,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human TDRD9/HIG1

Isotype: IgG

Information d'application

Indications d'application: ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur TDRD9

Antigène: TDRD9 (Tudor Domain Containing 9 (TDRD9))

Autre désignation: TDRD9/HIG1 (TDRD9 Produits)

Synonymes: anticorps MGC146806, anticorps C14orf75, anticorps HIG-1, anticorps NET54, anticorps 4930441E05Rik, anticorps si:dkey-15f17.9, anticorps tdrd9l, anticorps tudor domain containing 9, anticorps TDRD9, anticorps tdrd9, anticorps Tdrd9

Sujet:

Synonyms: C14orf75, chromosome 14 open reading frame 75, HIG 1, Hypoxia inducible HIG 1, MGC135025, Putative ATP dependent RNA helicase TDRD9, Putative ATP-dependent RNA helicase TDRD9, TDRD 9, Tdrd9, TDRD9_HUMAN , Tudor domain containing 9, Tudor domain containing protein 9, Tudor domain-containing protein 9.

Background: Probable ATP-binding RNA helicase which plays a central role during spermatogenesis by repressing transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Its association with PIWIL4 and the piP-bodies suggests a participation in the secondary piRNAs metabolic process.

ID gène: 122402